Analgesic Efficacy and Safety of Intravenous Meloxicam in Subjects With Moderate-to-Severe Pain After Open Abdominal Hysterectomy: A Phase 2 Randomized Clinical Trial

An intravenous (IV) formulation of meloxicam was developed for moderate-to-severe pain management. This study evaluated the safety and efficacy of meloxicam IV after open abdominal hysterectomy. Meloxicam IV is an investigational product not yet approved by the US Food and Drug Administration. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Rechberger, Tomasz, Mack, Randall J., McCallum, Stewart W., Du, Wei, Freyer, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Chronic Pain Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530966/
https://www.ncbi.nlm.nih.gov/pubmed/31094806
http://dx.doi.org/10.1213/ANE.0000000000003920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530966/
https://www.ncbi.nlm.nih.gov/pubmed/31094806
http://dx.doi.org/10.1213/ANE.0000000000003920

Ejemplares similares